Vincent Soriano Selected Research

Didanosine (Videx)

5/2010	Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings.
11/2008	Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients.
1/2008	Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome.
10/2007	Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study.
8/2006	Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosine.
4/2006	Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.
1/2005	The role of hepatitis C virus (HCV) in mitochondrial DNA damage in HIV/HCV-coinfected individuals.
5/2003	Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincent Soriano Research Topics

Disease

61	Infections 01/2018 - 01/2002
56	Chronic Hepatitis C 01/2016 - 01/2002
45	Hepatitis C 07/2017 - 07/2004
35	HIV Infections (HIV Infection) 10/2013 - 10/2002
29	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015 - 01/2004
26	Viremia 07/2017 - 07/2003
23	Chronic Hepatitis B 07/2017 - 11/2005
17	Fibrosis (Cirrhosis) 01/2018 - 09/2002
15	Coinfection 01/2015 - 07/2004
14	Acquired Immunodeficiency Syndrome (AIDS) 09/2015 - 05/2002
13	Hepatitis B 01/2018 - 01/2003
13	Liver Diseases (Liver Disease) 01/2017 - 12/2004
7	End Stage Liver Disease 11/2011 - 01/2004
6	Hepatitis D 01/2017 - 01/2011
6	Hepatitis 01/2013 - 01/2005
5	Anemia 02/2012 - 08/2005
5	Hypersensitivity (Allergy) 08/2010 - 05/2002
4	Neoplasms (Cancer) 07/2017 - 05/2007
4	Disease Progression 01/2015 - 04/2005
4	Hyperbilirubinemia 02/2009 - 01/2006
4	Pancreatitis 09/2006 - 05/2003
4	Lipodystrophy 07/2005 - 05/2002
4	Hyperlactatemia 12/2004 - 01/2003
3	Alcoholism (Alcohol Abuse) 08/2017 - 07/2004
3	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 07/2012 - 01/2003
3	Portal Hypertension 05/2010 - 01/2008
3	Opportunistic Infections (Opportunistic Infection) 09/2006 - 05/2003
2	Syphilis 10/2013 - 12/2004
2	Superinfection 04/2013 - 03/2010
2	Persistent Infection 02/2013 - 04/2011
2	Hemolytic Anemia 02/2012 - 04/2010
2	Hemorrhage 02/2011 - 11/2008
2	Virus Diseases (Viral Diseases) 10/2010 - 12/2004
2	Hyperglycemia 10/2010 - 04/2006
2	Diarrhea 02/2009 - 10/2003
2	Dyslipidemias (Dyslipidemia) 02/2009 - 04/2008
2	Exanthema (Rash) 10/2008 - 04/2008
2	Insulin Resistance 04/2008 - 01/2003
2	Fatty Liver 04/2008 - 03/2005
2	Spinal Cord Diseases 11/2007 - 06/2005
2	Hepatocellular Carcinoma (Hepatoma) 05/2006 - 12/2004

Drug/Important Bio-Agent (IBA)

42	RNA (Ribonucleic Acid)IBA 01/2017 - 05/2003
41	Ribavirin (Virazole)FDA LinkGeneric 01/2015 - 09/2002
36	InterferonsIBA 01/2015 - 09/2002
29	Antiviral Agents (Antivirals)IBA 07/2017 - 06/2005
25	Pharmaceutical PreparationsIBA 08/2017 - 07/2002
13	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 12/2004
13	Tenofovir (Viread)FDA Link 07/2017 - 01/2005
10	Lamivudine (Epivir)FDA Link 11/2013 - 01/2003
9	Transaminases (Aminotransferases)IBA 01/2008 - 05/2002
8	DNA (Deoxyribonucleic Acid)IBA 07/2017 - 11/2007
8	NucleosidesIBA 05/2012 - 07/2004
8	Didanosine (Videx)FDA LinkGeneric 05/2010 - 05/2003
7	EnzymesIBA 01/2018 - 12/2004
7	Protease Inhibitors (Protease Inhibitor)IBA 01/2015 - 10/2002
6	AntibodiesIBA 01/2018 - 05/2004
5	Reverse Transcriptase InhibitorsIBA 04/2011 - 07/2004
5	Nevirapine (Viramune)FDA Link 01/2010 - 01/2002
4	entecavir FDA Link 07/2017 - 06/2005
4	Raltegravir Potassium FDA Link 03/2013 - 10/2009
4	Hepatitis B e AntigensIBA 10/2012 - 06/2005
4	abacavir (Ziagen)FDA Link 08/2010 - 11/2007
4	efavirenz (Sustiva)FDA Link 01/2010 - 07/2003
4	Atazanavir Sulfate (Reyataz)FDA Link 02/2009 - 01/2006
4	Stavudine (Zerit)FDA LinkGeneric 04/2007 - 03/2004
4	Mitochondrial DNA (mtDNA)IBA 03/2007 - 03/2004
3	telaprevirIBA 07/2013 - 09/2012
3	InterleukinsIBA 07/2012 - 11/2011
3	Peptide Hydrolases (Proteases)FDA Link 04/2011 - 05/2002
3	LipidsIBA 10/2010 - 10/2002
3	HLA-B Antigens (HLA-B)IBA 08/2010 - 11/2007
3	NucleotidesIBA 07/2010 - 01/2005
3	Lopinavir FDA Link 02/2009 - 10/2003
3	Alanine Transaminase (SGPT)IBA 01/2009 - 05/2002
3	Interferon-alpha (Interferon Alfa)IBA 12/2008 - 06/2005
3	AntigensIBA 11/2007 - 10/2006
3	adefovirIBA 05/2007 - 06/2005
3	Zidovudine (Retrovir)FDA LinkGeneric 09/2006 - 05/2002
2	Integrase InhibitorsIBA 03/2015 - 09/2008
2	dolutegravirIBA 03/2015 - 03/2013
2	Hyaluronic Acid (Hyaluronan)IBA 01/2013 - 01/2011
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2013 - 09/2012
2	Inosine TriphosphataseIBA 03/2012 - 12/2011
2	Interleukin-7 (Interleukin 7)IBA 12/2011 - 11/2008
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2011 - 05/2003
2	IntegrasesIBA 04/2011 - 02/2010
2	Surface Antigens (Surface Antigen)IBA 03/2011 - 04/2008
2	Maraviroc FDA Link 12/2010 - 01/2010
2	tipranavir FDA Link 07/2010 - 10/2009
2	Hepatitis C AntibodiesIBA 03/2010 - 12/2004
2	Hydroxyurea (Hydrea)FDA LinkGeneric 08/2006 - 06/2004
2	Enfuvirtide (Fuzeon)FDA Link 07/2005 - 05/2004

Therapy/Procedure

104	Therapeutics 01/2017 - 07/2002
32	Highly Active Antiretroviral Therapy (HAART) 03/2012 - 10/2002
4	Duration of Therapy 06/2013 - 08/2007
3	Contraindications 12/2005 - 07/2004
2	Art Therapy 06/2014 - 01/2011
2	Aftercare (After-Treatment) 04/2011 - 11/2006
2	Liver Transplantation 01/2010 - 07/2004
2	Transplantation 06/2005 - 01/2003